Failure to thrive: Lessons learned from medtech innovations that missed the mark (MassDevice)
Some of the medical device industry’s most heralded disruptors wound up being its biggest failures. Here’s what we can learn from their mistakes.
No one in medtech sets out to fail. No one invests in building a device believing that, despite years of research and development, it won’t make the cut.
There are few other fields in which disruptive, innovative technologies can make waves as big as they do in medtech – where outcomes can be life or death.
The discovery and exploration of antibiotics revolutionized infection treatment and saved billions of lives. X-rays gave us an actual window into ourselves and changed how we view and treat the human body.
Advances in robotics are making surgeries faster and more repeatable and are returning mobility to paralyzed patients. Next-generation 3D-printed biologics and advances in DNA modification, such as CRISPR, aim to change how we develop and design regenerative therapeutic products.
But not all technologies – even seemingly well-vetted, cutting-edge innovations – manage to make an impact on the field. Many companies fall short when it comes to ...
